319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy
Publication
, Conference
Theivanthiran, B; Liu, F; DeVito, N; Plebanek, M; Hanks, B
Published in: Journal for ImmunoTherapy of Cancer
November 2021
Duke Scholars
Published In
Journal for ImmunoTherapy of Cancer
DOI
EISSN
2051-1426
Publication Date
November 2021
Volume
9
Issue
Suppl 2
Start / End Page
A343 / A343
Publisher
BMJ
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Theivanthiran, B., Liu, F., DeVito, N., Plebanek, M., & Hanks, B. (2021). 319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy. In Journal for ImmunoTherapy of Cancer (Vol. 9, pp. A343–A343). BMJ. https://doi.org/10.1136/jitc-2021-sitc2021.319
Theivanthiran, Balamayooran, Fang Liu, Nicholas DeVito, Michael Plebanek, and Brent Hanks. “319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy.” In Journal for ImmunoTherapy of Cancer, 9:A343–A343. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.319.
Theivanthiran B, Liu F, DeVito N, Plebanek M, Hanks B. 319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy. In: Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A343–A343.
Theivanthiran, Balamayooran, et al. “319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy.” Journal for ImmunoTherapy of Cancer, vol. 9, no. Suppl 2, BMJ, 2021, pp. A343–A343. Crossref, doi:10.1136/jitc-2021-sitc2021.319.
Theivanthiran B, Liu F, DeVito N, Plebanek M, Hanks B. 319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy. Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A343–A343.
Published In
Journal for ImmunoTherapy of Cancer
DOI
EISSN
2051-1426
Publication Date
November 2021
Volume
9
Issue
Suppl 2
Start / End Page
A343 / A343
Publisher
BMJ
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology